Beirunning Appears at Zhejiang Ophthalmology Annual Meeting
Release time:
2020-07-22
Beirunning Appears at Zhejiang Ophthalmology Annual Meeting
News 11# July 15 - 17 , Zhejiang Institute of Integrated Traditional Chinese and Western Medicine Ophthalmology Annual Meeting Held in Huzhou, Zhejiang Province. Peak Pharmaceutical Company brought its products to the annual meeting and introduced Beirunning (Olopatadine Hydrochloride Eye Drops), the first domestic product that passed the consistency evaluation.
This annual meeting is co-sponsored by the Visual Function Professional Committee of Zhejiang Rehabilitation Medicine Association, the Ophthalmology Professional Committee of Zhejiang Integrative Medicine Association, and the Ophthalmology Professional Committee of Huzhou Medical Association. It is hosted by Zhejiang Hospital. There are mainly national continuing medical education class "New Progress in Diagnosis and Treatment of Visual Function Rehabilitation", and provincial continuing medical education class "Diagnosis and Treatment of Difficult Ophthalmology Diseases by Traditional Chinese and Western Medicine", the provincial continuing medical education class "integrated traditional Chinese and western medicine prevention and treatment of diabetic retinopathy seminar" and other content.
. At this annual meeting, the pharmaceutical company invited Zhang Huicheng, president of Hangzhou Qiushi Hospital and former president of the ophthalmology annual meeting of Zhejiang Integrated Traditional Chinese and Western Medicine Association, to introduce Jianfeng Pharmaceutical and Berunning products. He introduced in detail the causes of allergy, how to choose anti-eye allergy drugs, why to choose anti-allergy drugs with double-effect mechanism, and why to choose Berunning Olopatadine Hydrochloride Eye Drops of Zhejiang Jianfeng Pharmaceutical Co., Ltd. Beirunning is the first eye drops that have passed the consistency evaluation in China, and with its unique efficacy of antagonizing histamine H1- receptors, stabilizing mast cells and two-way anti-allergy has received widespread attention. Beirunning in the treatment of children with allergic conjunctivitis has good effect, fast curative effect, will not cause significant mast cell degranulation, so the use of more safe, and almost no adverse reactions to the eye tissue, is the current treatment of allergic conjunctivitis an ideal drug. Beirunning products have been unanimously recognized and praised by on-site ophthalmologists.
Participating in this annual meeting has improved the recognition of Berunning in Zhejiang ophthalmologists and laid a good foundation for the market promotion of Berunning in the later period. (Lin Xu)
More information
Peak re-listed China's top 100 cement production capacity Daye peak won the "smart factory leader"
On July 11-12, the 2022 China Cement Industry Summit and TOP100 Award Ceremony organized by China Cement Network, an authoritative media of China's cement industry, was held in Hangzhou. Jianfeng Group once again ranked among the top 100 cement clinker production capacity in China.
2022
08-04
On the afternoon of July 12, the party Committee of the group company held a special meeting attended by party Committee members, senior and middle-level management backbones, heads of grass-roots party organizations and all party members of the group headquarters to learn and convey the spirit of the 15th party congress of the communist party of China in Zhejiang province.
2022
07-24
On the morning of July 1, more than 40 members of the group's party committee, party members of various branches of the group headquarters, and party members of subordinate enterprise branches went to the Shuanglong Hydropower Station, the Red Education Base of Jinhua City, to receive party spirit and revolutionary tradition education.
2022
07-14
Vocational skill level identification examination!
On June 16 and 18, the theoretical and practical examinations for the determination of professional skill level in the peak pharmaceutical sector were held successively in Jinxi pharmaceutical factory. The independent identification of vocational skill level includes three occupations (types of work): pharmaceutical preparation worker, chemical inspector and organic synthesis worker, basically covering the main posts in the pharmaceutical sector, with a total of 125 employees signing up for the identification.
2022
06-21
On June 16, the Jianfeng Pharmaceutical Quality Research and Development Party Branch and the Jinhua Vocational Skills Management Service Center Party Branch held a signing ceremony in Jinxi Factory to establish a party building alliance.
2022
06-21
Jinhua Mayor Xing Zhihong to Peak Research
On the afternoon of June 1, Jinhua Mayor Xing Zhihong, Wucheng District Party Committee Secretary Gao Feng, District Mayor Hu Yuxian, and heads of the Municipal Economic and Information Bureau, Development and Reform Bureau and other departments went to the group headquarters to discuss and exchange with the leaders of the group company to understand the development of the enterprise. Solicit opinions and suggestions from enterprises on government work. After understanding the current business situation of the peak, Xing Zhihong pointed out that focus, follow the right path, frontier, steady, is the peak to long-term prosperity of the magic weapon, must continue to adhere.
2022
06-13
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page